Doron Yablecovitch

6PUBLICATIONS
7CO-AUTHORS
Metabolic medicinePredictive and prognostic markersDisease surveillanceMedical virologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2025
Fecal and Serum Metabolome in Crohn's Disease is Linked With Future Flare.

Nina Levhar, Rotem Hadar, Tzipi Braun

|Sep 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma.

Doron Yablecovitch, Moshe Nadler, Shomron Ben-Horin

|Aug 03, 2023
Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn's disease.

Offir Ukashi, Doron Yablecovitch, Adi Lahat

|Jul 22, 2023
Serum matrix metalloproteinase-7: a potential biomarker in patients with Lynch Syndrome.

Doron Yablecovitch, Hussein Mahajna, Nir Horesh

|Oct 23, 2019
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.

Doron Yablecovitch, Uri Kopylov, Adi Lahat

|Dec 28, 2016
Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.

D Yablecovitch, A Oren, S Ben-Horin

Pageof 1

Frequent Collaborators

3 joint publications

Uri Kopylov

2 joint publications

Adi Lahat

1 joint publications

Offir Ukashi

1 joint publications

Ido Laish